Osimertinib in patients with epidermal growth factor receptor T790M advanced non‐small cell lung cancer selected using cytology samples

Osimertinib is a potent, irreversible epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) selective for EGFR‑TKI sensitizing (EGFRm) and T790M resistance mutations. The primary objective of the cytology cohort in the AURA study was to investigate safety and efficacy of osimertini...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Sci
Main Authors: Kiura, Katsuyuki, Yoh, Kiyotaka, Katakami, Nobuyuki, Nogami, Naoyuki, Kasahara, Kazuo, Takahashi, Toshiaki, Okamoto, Isamu, Cantarini, Mireille, Hodge, Rachel, Uchida, Hirohiko
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2018
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5891183/
https://ncbi.nlm.nih.gov/pubmed/29363250
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.13511
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados